Literature DB >> 31907390

Saga of Mcl-1: regulation from transcription to degradation.

Viacheslav V Senichkin1, Alena Y Streletskaia1, Anna S Gorbunova1, Boris Zhivotovsky2,3, Gelina S Kopeina4.   

Abstract

The members of the Bcl-2 family are the central regulators of various cell death modalities. Some of these proteins contribute to apoptosis, while others counteract this type of programmed cell death, thus balancing cell demise and survival. A disruption of this balance leads to the development of various diseases, including cancer. Therefore, understanding the mechanisms that underlie the regulation of proteins of the Bcl-2 family is of great importance for biomedical research. Among the members of the Bcl-2 family, antiapoptotic protein Mcl-1 is characterized by a short half-life, which renders this protein highly sensitive to changes in its synthesis or degradation. Hence, the regulation of Mcl-1 is of particular scientific interest, and the study of Mcl-1 modulators could aid in the understanding of the mechanisms of disease development and the ways of their treatment. Here, we summarize the present knowledge regarding the regulation of Mcl-1, from transcription to degradation, focusing on aspects that have not yet been described in detail.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31907390      PMCID: PMC7206148          DOI: 10.1038/s41418-019-0486-3

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  138 in total

Review 1.  BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.

Authors:  Delphine Merino; Gemma L Kelly; Guillaume Lessene; Andrew H Wei; Andrew W Roberts; Andreas Strasser
Journal:  Cancer Cell       Date:  2018-12-10       Impact factor: 31.743

2.  MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.

Authors:  K M Kozopas; T Yang; H L Buchan; P Zhou; R W Craig
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 3.  Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy.

Authors:  Viacheslav V Senichkin; Alena Y Streletskaia; Boris Zhivotovsky; Gelina S Kopeina
Journal:  Trends Cell Biol       Date:  2019-04-25       Impact factor: 20.808

Review 4.  Mcl-1; the molecular regulation of protein function.

Authors:  Luke W Thomas; Connie Lam; Steven W Edwards
Journal:  FEBS Lett       Date:  2010-06-11       Impact factor: 4.124

5.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

Authors:  Z N Oltvai; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

Review 6.  Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins.

Authors:  Rumani Singh; Anthony Letai; Kristopher Sarosiek
Journal:  Nat Rev Mol Cell Biol       Date:  2019-03       Impact factor: 94.444

Review 7.  MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis.

Authors:  R W Craig
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

8.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

9.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

10.  Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2.

Authors:  E Y Lin; A Orlofsky; M S Berger; M B Prystowsky
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

View more
  33 in total

1.  Mcl-1-mediated mitochondrial fission protects against stress but impairs cardiac adaptation to exercise.

Authors:  Alexandra G Moyzis; Navraj S Lally; Wenjing Liang; Leonardo J Leon; Rita H Najor; Amabel M Orogo; Åsa B Gustafsson
Journal:  J Mol Cell Cardiol       Date:  2020-07-25       Impact factor: 5.000

2.  Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.

Authors:  Kaixuan Shi; Haijiao Lu; Zhenfeng Zhang; Yujie Fu; Jie Wu; Shichao Zhou; Pengfei Ma; Kaiyan Ye; Shengzhe Zhang; Hailei Shi; Weiping Shi; Mei-Chun Cai; Xiaojing Zhao; Zhuang Yu; Jian Tang; Guanglei Zhuang
Journal:  Cell Death Differ       Date:  2022-09-28       Impact factor: 12.067

Review 3.  Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.

Authors:  Rui Qin; Feng-Ming You; Qian Zhao; Xin Xie; Cheng Peng; Gu Zhan; Bo Han
Journal:  J Hematol Oncol       Date:  2022-09-14       Impact factor: 23.168

4.  siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells.

Authors:  Supusson Pengnam; Purin Charoensuksai; Boon-Ek Yingyongnarongkul; Rungnapha Saeeng; Hasan Uludağ; Prasopchai Patrojanasophon; Praneet Opanasopit; Samarwadee Plianwong
Journal:  Pharmaceutics       Date:  2022-06-03       Impact factor: 6.525

Review 5.  Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.

Authors:  Kyu Sic You; Yong Weon Yi; Jeonghee Cho; Jeong-Soo Park; Yeon-Sun Seong
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

Review 6.  Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.

Authors:  Hae-Seul Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

7.  Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.

Authors:  Asma Bourafai-Aziez; Mohammed Benabderrahmane; Hippolyte Paysant; Louis-Bastien Weiswald; Laurent Poulain; Ludovic Carlier; Delphine Ravault; Marie Jouanne; Gaël Coadou; Hassan Oulyadi; Anne-Sophie Voisin-Chiret; Jana Sopková-de Oliveira Santos; Muriel Sebban
Journal:  Drug Des Devel Ther       Date:  2021-12-15       Impact factor: 4.162

8.  Phosphatase PP2A enhances MCL-1 protein half-life in multiple myeloma cells.

Authors:  Anne Slomp; Laura M Moesbergen; Eric Eldering; Marie José Kersten; Monique C Minnema; Victor Peperzak
Journal:  Cell Death Dis       Date:  2021-03-03       Impact factor: 8.469

9.  A novel Schiff base cobalt(III) complex induces a synergistic effect on cervical cancer cells by arresting early apoptosis stage.

Authors:  Wen-Hui Liao; Xue-Qing Song; Yan-Jie Kong; Rui-Dan Bao; Fang-Fang Li; Jie Zhou; Qi-Hua Zhao; Jing-Yuan Xu; Ni Xie; Ming-Jin Xie
Journal:  Biometals       Date:  2021-01-03       Impact factor: 2.949

Review 10.  To Ubiquitinate or Not to Ubiquitinate: TRIM17 in Cell Life and Death.

Authors:  Meenakshi Basu-Shrivastava; Alina Kozoriz; Solange Desagher; Iréna Lassot
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.